Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammatory bowel disease in children

P M Hofley1, D A Piccoli

  • 1Section of Gastroenterology and Hepatology, Children's Hospital of Philadelphia, Pennsylvania.

The Medical Clinics of North America
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate.

Human mutation·2006
Same author

Consequences of JAG1 mutations.

Journal of medical genetics·2003
Same author

Alagille syndrome and the Jagged1 gene.

Seminars in liver disease·2001
Same author

Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease.

The American journal of gastroenterology·2001
Same author

Pediatric Crohn's disease: risk factors for postoperative recurrence.

The American journal of gastroenterology·2001
Same author

Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients.

Human mutation·2001
Same journal

Care Transitions Continue to Evolve.

The Medical clinics of North America·2026
Same journal

Navigating the Gaps: A Comprehensive Overview of Care Transitions Across the Continuum.

The Medical clinics of North America·2026
Same journal

Care Transitions and Value-Based Payment Models in the United States.

The Medical clinics of North America·2026
Same journal

Technology and Innovation in Care Transitions: Imagining the Future of Postdischarge Care.

The Medical clinics of North America·2026
Same journal

Primary Care, Specialists, and Hospitals: Bridging the Gaps in Communication and Coordination.

The Medical clinics of North America·2026
Same journal

Social Determinants of Health: Unique Considerations in Transitions of Care.

The Medical clinics of North America·2026
See all related articles

Inflammatory Bowel Disease (IBD) in children presents unique challenges, impacting growth and psychological well-being. Optimal management requires understanding pediatric-specific differences for better outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Chronic Disease Management
  • Inflammatory Bowel Disease (IBD)

Background:

  • Inflammatory Bowel Disease (IBD), encompassing Ulcerative Colitis (UC) and Crohn's Disease (CD), significantly affects children and adolescents.
  • While sharing similarities with adult IBD, pediatric cases present unique challenges in presentation, disease course, and management.
  • Endoscopic evaluations of the colon and terminal ileum are feasible in most pediatric patients.

Purpose of the Study:

  • To highlight the distinct aspects of pediatric Inflammatory Bowel Disease (IBD) compared to adult IBD.
  • To emphasize the critical need for pediatric-specific research and management strategies.
  • To underscore the importance of addressing growth, pubertal development, and psychological impact in pediatric IBD.

Main Methods:

Related Experiment Videos

  • Review of existing literature and clinical understanding of pediatric Inflammatory Bowel Disease (IBD).
  • Analysis of challenges in extrapolating adult IBD data to pediatric populations.
  • Emphasis on the necessity of tailored therapeutic assessments for growth and development.

Main Results:

  • Growth failure due to malnutrition is a serious complication in pediatric IBD patients.
  • The psychological impact on children and families is substantial.
  • Limited controlled studies specific to pediatric IBD have historically complicated management.

Conclusions:

  • Managing pediatric IBD requires a deep understanding of differences from adult IBD to optimize growth and minimize long-term sequelae.
  • Collaborative research efforts are crucial for advancing the optimal care of children and adolescents with IBD.
  • Future research should focus on therapies that address both disease activity and developmental outcomes.